Pacira BioSciences Inc. (PCRX)
NASDAQ: PCRX
· Real-Time Price · USD
26.05
-0.16 (-0.61%)
At close: Sep 24, 2025, 3:59 PM
26.05
0.00%
After-hours: Sep 24, 2025, 04:20 PM EDT
-0.61% (1D)
| Bid | 25.8 |
| Market Cap | 1.17B |
| Revenue (ttm) | 705.85M |
| Net Income (ttm) | -127.46M |
| EPS (ttm) | -2.75 |
| PE Ratio (ttm) | -9.47 |
| Forward PE | 8.12 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 27.51 |
| Volume | 344,999 |
| Avg. Volume (20D) | 664,252 |
| Open | 26.23 |
| Previous Close | 26.21 |
| Day's Range | 25.90 - 26.36 |
| 52-Week Range | 13.79 - 27.64 |
| Beta | 0.42 |
| Ex-Dividend Date | n/a |
About PCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPacira BioSciences Inc. is scheduled to release its earnings on
Nov 5, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 months ago
+14.67%
Pacira BioSciences shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
-0.82%
Pacira BioSciences shares are trading higher after the company announced settlement of litigation related to EXPAREL patents.
